已发表论文

奥利西瑞啶研究(2013 - 2024 年)的文献计量学与可视化分析

 

Authors Song C, Huang X, Chen N, Song Q, Qiu Y 

Received 26 October 2024

Accepted for publication 17 February 2025

Published 24 February 2025 Volume 2025:19 Pages 1305—1321

DOI https://doi.org/10.2147/DDDT.S497186

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Prof. Dr. Tamer M. Ibrahim Abdelrehim

Cheng Song,1,* Xinxing Huang,2,* Nianping Chen,1 Qiliang Song,3 Yuanli Qiu1 

1Department of Anesthesiology, Affiliated Hospital of Shaoxing University, Zhejiang, 312000, People’s Republic of China; 2Department of Anesthesiology, Jinhua Maternal and Child Health Hospital, Zhejiang, 321000, People’s Republic of China; 3Department of Anesthesiology, Shaoxing People’s Hospital, Shaoxing, Zhejiang, 312000, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Yuanli Qiu, Department of Anesthesiology, Affiliated Hospital of Shaoxing University, Shaoxing, Zhejiang, 312000, People’s Republic of China, Email QiuYuanli0706@163.com

Purpose: To explore and analyze the current research progress, hotspots, and future trends in oliceridine research using bibliometric methods.
Patients and Methods: We searched the Web of Science (WOS) database utilizing the keywords TS = (“oliceridine*” OR “TRV 130*” OR “TRV-130*” OR “olinvyk*” OR “TRV130*” OR “C22H31CIN2O2S*”) for relevant research literature on oliceridine from its inception to June 16, 2024. Bibliometric methods were applied, and analysis software such as VOSviewer and CiteSpace were used to visualize the publication timeline, authors, countries and regions, keywords, sources of literature, research hotspots, and co-cited documents related to oliceridine. Co-occurrence and aggregation analyses were conducted, and maps relevant to institutional cooperation were generated.
Results: A total of 151 relevant articles were retrieved and included in the final analysis. Most articles were published between 2020 and 2021. The United States has the highest number of publications and citations in this field. Molecular structure development is a pivotal point in this field. Research hotspots were diverse, including acute pain, opioid receptors, β-arrestin, postoperative pain, therapeutic window, respiratory depression, clinical trials, and chronic pain.
Conclusion: Oliceridine, a newly developed analgesic, has garnered global interest. The USA is a leading contributor to this field. Recent research has shifted from basic studies to clinical practice.

Keywords: oliceridine, bibliometrics, opioid drugs, research trends